- David's June 2019 Keynote presentation at the Harvard i2b2 Transmart Foundation, introduced by Dr. Zak Kohane, Chair of the Department of Biomedical Informatics (DBMI), Harvard Medical School; David's talk is entitled "Data Science and Technology: The Pharma Perspective."
- David was interviewed for a 2019 episode of Harvard Business School's "Under the Datascope" podcast, available here. Episode description: Healthcare digitization is booming and data-driven innovations are disrupting drug discovery. But we must learn how to use these emerging technologies better so that we can ask more sophisticated questions, and come up with deeper insights into biology and the understanding and treatment of disease. David Shaywitz talks about disruptive innovators and offers some sober views on how hard it is to re-invent drug R&D.
- Since January 2015, David, together with Lisa Suennen, have co-hosted the "Tech Tonics" podcast, focused on "the people and passion at the intersection of technology and health." The show is available on on iTunes (here). Featured guests (with links to their episodes) include, among many others, Bob Wachter (UCSF), Robert Plenge (BMS, ex-Celgene, Broad), Taha Kass-Hout (Amazon, ex-FDA), Chris Benko (Koneksa, ex-Merck), Deb Kilpatrick (Evidation), Jess Mega (Verily), Eric Perakslis (Duke/Harvard, ex-FDA, J&J, Takeda), Glen de Vries (Medidata), Zak Kohane (Harvard), Jeff Reid (Regeneron), Joel Dudley (Tempus, ex-MSSM), Amy Abernethy (FDA, ex-Flatiron), Atul Butte (UCSF), Ken Tarkoff (Syapse, ex-RelayHealth, McKesson), Daphne Koller (insitro, ex-Calico, Coursera), Amir Dan Rubin (One Medical, ex-Optum, Stanford Hospitals), David van Sickle (Propeller Health), Gini Despenshade (Numedii), Iya Khalil (GNS Healthcare), Dave Albert (AliveCor), Katherine Chou (Google), Amalio Talenti (Vir, ex-Broad, HLI), Stephanie Tilenius (Vida Health), Noah Craft (Science37), Owen Tripp (Grand Rounds), Brad Hirsch (SignalPath), Sek Kathiresan (Verve, ex-MGH/Broad), Simon Kos (Microsoft), Ari Caroline (Tempus, ex-MSKCC), Darshak Sanghavi (OptumLabs), Susan Desmond-Hellmann (Gates Foundation, ex-Genentech), Allison Kurian (Stanford), Andy Coravos (Elektra Labs), Calum MacRae (Harvard), Imran Haque (Recursion, ex-Counsyl, Freenome), Marcus Osborn (Walmart), Chris Gibson (Recursion), Kari Nadeau (Stanford), David Altshuler (Vertex, ex-Broad), Jim Manzi (Foundry.ai, ex-Applied Predictive Technologies).
For more than 25 years, David has been translating for a generalist audience the complexities of issues at the intersection of science, medicine, and technology, contributing frequently to publications such as the New York Times, Wall Street Journal, Washington Post, Financial Times, and Boston Globe, among others. From 2011-2019, he blogged about entrepreneurial innovation in medicine and biopharma for Forbes. In November 2019, he moved his blog, now titled "Astounding HealthTech," to The Timmerman Report. Links to recents posts about the challenges of introducing digital and data science into pharma, the implementation/diffusion of new technology, AI and its discontents, and others topics can be found here.